PHARMA
16 Jan ’24 — Nifty Tests the Ascending Channel Today - stance ➡️Nifty Analysis - Stance Neutral ➡️
Recap from yesterday: “Remember how things were looking weak on the 8th and 10th of Jan and how Nifty turned from there? For tomorrow, the bullish stance continues and the first support will be the ascending channel top-line ~ 22050 levels.”
4mts chart
Nifty hit a new top of 22124 today and just when everything was going in its favor, it started falling. Most analysts will blame the NiftyIT sector (-1.28%) for the fall today - they are not wrong but it is not just because of IT. The majority of the Nifty sub-sectors were down today, Realty (-1.66%), Pharma (-1.14%), Energy (-0.75%), Service (-0.52%). Very few sectors were in green today - Metal, Media, Consumer Durables, PSU banks, etc. When the majority of sectors are against the primary direction (bullish), it may end up becoming a top-like formation.
We discussed yesterday how the Ascending Channel will act like support, on the 4mts TF we got a breach today. 22050 was our laxman rekha but we ended up hitting 21969.
63mts chart
The channel top is not breached in the higher TF, just because of this we are not changing the stance from bullish to bearish. We would like to give one more opportunity for Nifty to hold its ground. We would start the day tomorrow with a neutral bias and wait for Nifty to fall below 21913 to go bearish.
Range breakout in supriya lifescienceSupriya lifescience has given a range breakout in weekly chart. Stock is consolidating near the support .
Good oppurtunity to long for a Target1 of 400 and T2 450.
Keep sl at near recent swing around 310.
This is just my personal view on the stock .
This is not a recommendation . I am not a SEBI registered advsior.
Thank you !
Prescription for Profit: Unlocking Glenmark Pharma's Potential.Glenmark Pharma, CMP - Around 788
If the closing price of Glenmark Pharma surpasses 797, I am contemplating a buy position above the 800 mark. To mitigate potential losses, a stop-loss order will be strategically placed below 760. Our anticipated price targets are set at 840 and 880, with consideration for trailing if market conditions prove favorable.
Sequent Scientific PE is negative at -42
THE CARLYLE GROUP ACQUIRES A MAJORITY STAKE IN SEQUENT SCIENTIFIC LIMITED
Shares of Sequent Scientific soared over 9 percent in early trade on September 15 after the company's board approved the sale of its API (Active Pharmaceutical Ingredient) facility in Thane
Sequent Scientific (NSE:SEQUENT) delivers shareholders decent 8.8% CAGR over 5 years
Sequent Scientific shares jump 15% after terminating Tineta Pharma's proposed acquisition
mutual funds have increased stake from 0.25% to 1%
DII also increasing stake significantly
stock has come out of accumulation Phase!!!
You will earn 30% Swing Pick (1-3 Month apx)
LYKA LABORATORIES (LYKALABS) – {CMP-124.9}
Technically Very Strong💹
(Refer Chart)
Target🎯: 30% Upside expected
SL : 105 (15% Apx)
Disclaimer🙏 : This is not a Buy/Sell advice. We share what we do. Only for educational purpose. Consult your financial advisor before investing.
📈 Exciting Bullish Pattern Alert! 🐂📈 Exciting Bullish Pattern Alert! 🐂
📊 Pattern: Head & Shoulder
📌 Symbol/Asset: LALPATHLAB
🔍 Description: Stock has given a breakout of Head & Shoulder pattern and now retested the neck line. So its very likely stock will bounce from the neck line and we cann see momentum on the upside !!!
👉 Disclosure: We are not SEBI registered analysts, this is not a buy or sell recommendation. Technical patterns are just one piece of the puzzle. Consider conducting further research, consulting with a financial advisor, and managing your risks appropriately.
DRREDDY, 1D Forms Bullish MarubozuNSE:DRREDDY Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas.
DRREDDY forms Bullish Marubozu on support zone of Weekly TF
Entry : 5673.8
Target : 5890
SL : 5540
RR : 1.6
LALPATHLAB, 1D formed Bullish HaramiNSE:LALPATHLAB Dr Lal PathLabs Limited is an Indian service provider of diagnostic and related healthcare tests. Based in New Delhi, the company offers tests on blood, urine and other human body viscera.
After a downtrend, Lalpathlab gave BO of Bullish Harami candlestick pattern.
Entry : 2239.35
Target : 2352
SL : 2155
RR : 1.34
BIOCONHello & welcome to this analysis
Stock is among the rare few which had a lengthy period of correction which broke the Covid lows.
Its trying to reverse as can be seen in lower time frame but higher time frame still lacks confirmation and is suggesting volatility.
I have explained the levels on both sides which would give a clearer direction of trend.
Hope this helps
Happy Investing
Divislab,1D formed HammerDivi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates.
Hammer formed in Divislab , 1d with parallel channel support
Entry : 3629
Target : 3735
SL : 3525
RR : 1
Sun pharma,1D formed Bullish MarubozuNSE:SUNPHARMA Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries across the globe.
Sunpharma gave BO of Bullish Marubozu candle on Daily TF.
Entry : 1136.9
Target : 1169
SL : 1099
RR :0.85